Detection of Point Mutations Associated with Resistance of Helicobacter pylori to Clarithromycin by Hybridization in Liquid Phase
- 1 November 1998
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (11) , 3285-3290
Abstract
When the standard procedure for determining antibiotic susceptibility of bacteria is used, the results are delayed, especially for bacteria that grow slowly, such as Helicobacter pylori . Treatment for this bacterium may involve clarithromycin, a compound for which resistance has been associated with point mutations on the 23S rRNA gene. This resistance is currently found in organisms isolated from 0 to 15% of patients and jeopardizes the success of the treatment. We have designed a test involving amplification and colorimetric hybridization in the liquid phase to detect the mutation at the molecular level. First, four reference strains, including the wild type and three strains with the mutations A2143C, A2143G, and A2144G, were used to optimize the method. Amplification was carried out with primers previously published. The amplified products were added to probe-coated microtiter wells. A DNA enzyme immunoassay was used to detect the hybrids. The optimal conditions of the hybridization were defined for each probe. Nineteen H. pylori strains resistant to clarithromycin and 22 susceptible according to phenotypic data were submitted to restriction with Bsa I and Bbs I, and part of the 23S rRNA gene was sequenced in order to determine the mutation involved for the resistant strains. The new assay showed a complete correlation with the reference methods, except for one strain. Cross-hybridizations as well as application of the reaction to other bacteria did not lead to optical densities higher than the cutoff values chosen with the receiving operating characteristic curve. This method can be easily standardized and gives a result within a day. Its application directly to the biopsy specimens or infected gastric juice is planned in the future.Keywords
This publication has 24 references indexed in Scilit:
- Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcerAlimentary Pharmacology & Therapeutics, 1997
- Evaluation of rapid molecular methods for detection of clarithromycin resistance inHelicobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Identification of a 23S rRNA Gene Mutation in Clarithromycin‐Resistant Helicobacter pyloriHelicobacter, 1996
- Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I StudyHelicobacter, 1996
- Mechanism of clarithromycin resistance in clinical isolates ofHelicobacter pyloriFEMS Microbiology Letters, 1996
- Simultaneous detection of ΔF508, G542X, N1303K, G551D, and 1717-1G→A cystic fibrosis alleles by a multiplex DNA enzyme immunoassayInternational Journal of Clinical and Laboratory Research, 1995
- Rapid detection ofSalmonellasubspecies I by PCR combined with non-radioactive hybridisation using covalently immobilised oligonucleotide on a microplateFEMS Immunology & Medical Microbiology, 1995
- Mutation detection by denaturing gradient gel electrophoresis (DGGE)Human Mutation, 1994
- PCR amplification of specific alleles: Rapid detection of known mutations and polymorphismsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reactionGenomics, 1989